日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of gastrointestinal malignancies

使用GLP-1受体激动剂重新评估癌症风险:一项关于胃肠道恶性肿瘤的综合荟萃分析

Wali, Adil Farooq; Rangraze, Imran; Khan, Shehla; Mufti, Uwais Bashir; El-Tanani, Mohamed; Rizzo, Manfredi

Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials

天然产物作为肺癌激酶抑制剂:分子机制、治疗潜力和临床试验

Wali, Adil Farooq; Talath, Sirajunisa; Babiker, Rasha; El-Tanani, Mohamed; Rangraze, Imran Rashid; Ibraheem, Walaa; Al Aldhaheri, Yusra; Satyam, Shakta Mani; El-Tanani, Yahia

Ambient-Stable mRNA Medicines: Emerging Paradigms in Dry and Solid-State Formulation

环境稳定型mRNA药物:干粉和固态制剂的新兴范式

El-Tanani, Mohamed; Rabbani, Syed Arman; Wali, Adil Farooq; Muhana, Frezah; Aljabali, Alaa A A; El-Tanani, Yahia; Kumar, Rakesh

Correction: Redefining pancreatogenic diabetes mellitus through molecular, imaging, and AI-driven evidence

更正:通过分子、影像和人工智能驱动的证据重新定义胰源性糖尿病

Rangraze, Imran Rashid; El-Tanani, Mohamed; Wali, Adil Farooq; Babiker, Rasha; Rabbani, Syed Arman; Matalka, Ismail I; Satyam, Shakta Mani; Avagimyan, Ashot; Hoffmann, Karolina; Ilias, Ioannis; Ispas, Sorina; Viviana, Maggio; Paczkowska, Anna; Rizzo, Manfredi

Pimozide Reprograms the Ran GTPase-SCF Axis and Matrix Remodeling Pathways in Breast, Colorectal, and Pancreatic Cancer Models

匹莫齐特可重编程乳腺癌、结直肠癌和胰腺癌模型中的 Ran GTPase-SCF 轴和基质重塑通路

Al-Ali, Hayat Asaad Hameed; El-Tanani, Mohammad; Satyam, Shakta Mani; Al-Qaisi, Talal Salem; Lukman, Yusuf; Ahmed, Khaled A; Obiedat, Razan; Ibrahim, Abubakar; Madi, Razan; Khirfan, Rahmeh

Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management

以时间药理学为导向的精准疗法,用于优化心血管代谢疾病的治疗管理

Satyam, Shakta Mani; Prabhakar, Sainath; El-Tanani, Mohamed; Bhongade, Bhoomendra; Wali, Adil Farooq; Rangraze, Imran Rashid; Matalka, Ismail Ibrahim Ali; El-Tanani, Yahia; Rizzo, Manfredi; Ispas, Sorina; Ilias, Ioannis; Paczkowska, Anna; Maggio, Viviana; Hoffmann, Karolina

Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1

下一代癌症免疫疗法靶向PD1和PD-L1以外的机制

El-Tanani, Mohamed; Satyam, Shakta Mani; Rabbani, Syed Arman; Rangraze, Imran Rashid; Matalka, Ismail Ibrahim Ali; Muhana, Frezah; El-Tanani, Yahia; Aljabali, Alaa A A; Khan, Mohammad Ahmed; Parvez, Suhel; Porntaveetus, Thantrira

Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy

利用计算机辅助手段重新定位已获批准的靶向KRAS G12D和EGFR的药物,用于结直肠癌治疗

Ibraheem, Walaa; Alsheikh, Fatima; Alzain, Abdulrahim A; Bhongade, Bhoomendra A; Ejaz, Laila; Baig, Hamnah; Robinson, Robert C; El-Tanani, Mohamed

Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A

利用甲苯咪唑重塑致癌和抑癌网络:来自 ENOX2、MMP2、RASSF1A、WFDC10A 和 METTL7A 的多癌种治疗启示

Aqel, Rasha Shaker; Ismail, Areej Sami; El-Tanani, Mohamed; Satyam, Shakta Mani

Inclisiran SiRNA therapy for durable LDL-C reduction: a systematic review and meta-analysis highlighting a breakthrough in long-term cardiovascular risk management

Inclisiran siRNA疗法可持久降低LDL-C水平:一项系统评价和荟萃分析凸显了长期心血管风险管理方面的突破

Satyam, Shakta Mani; El-Tanani, Mohamed; Patni, Mohamed Anas; Rehman, Abdul; Irshad, Sara Muhammad; Raheem, Reem; Junais, Esha; John, Ashika Anu; Rassal, Rena Yusuf; Kumari, Rashmi; P, Sainath